(iii) Consider novel CVD risk markers included in cardiac remodelling, endothelial dysfunction etc. (i.e., apolipoprotein M, matrix metalloproteinases, intercellular cell adhesion molecule-1, etc.)and (iv) Carefully monitor and report potential adverse effects of exercise. This evidence concerns the gene APOM and endothelial dysfunction.